Company
Alpheus Medical
Alpheus Medical | Developing a New Drug-Ultrasound Therapy for Glioblastoma
- Business model
- B2B
- Legal name
- Alpheus Medical, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Alpheus is advancing a new therapeutic approach designed to improve outcomes while reducing treatment burden for patients and families.
Funding snapshot
- Total raised
- $56.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $60.5M2025-05-02
Funding rounds
- Round, 2025
- $60.5M2025-05-02, SEC form D sold, 22 investors
- Round, 2022
- $14M2022-10-25, SEC form D sold, 4 investors
- Round, 2020
- $6M2020-12-16, SEC form D sold, 23 investors
- Round, 2019
- $519K2019-10-04, SEC form D sold, 12 investors
- Round, 2018
- $1.3M2018-04-25, SEC form D sold, 22 investors
- Round, 2018
- $150K2018-01-21, SEC form D sold, 2 investors
- Round, 2017
- $225K2017-05-24, SEC form D sold, 2 investors
Loading relationship preview